Combined Immuno-chemotherapy for Patients With B-linear Acute Lymphoblastic Leukemia Diagnosed From 0 to 365 Days of Life (ALL-Baby-2021)
Clinical trial NCT05029531 · RECRUITING
Trial details
- NCT number
- NCT05029531
- Sponsor
- Federal Research Institute of Pediatric Hematology, Oncology and Immunology
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-23
- Primary completion
- 2029-07-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.